OSLO, Norway--(BUSINESS WIRE)--Nordic Nanovector ASA (OSE: NANO), a company focusing on the development and commercialization of novel targeted therapeutics in haematology and oncology, announces the formation of a new Scientific Advisory Board (SAB). The SAB includes experts in haematology-oncology and cancer drug development from leading academic/research institutions in the US and Europe.
Help employers find you! Check out all the jobs and post your resume.
Help employers find you! Check out all the jobs and post your resume.
